$XENT

Intersect ENT Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Medicinal and Botanical Manufacturing

PRICE

$28.24 -

Extented Hours

VOLUME

837,170

DAY RANGE

28.23 - 28.25

52 WEEK

0 - 28.25

Join Discuss about XENT with like-minded investors

profile
@dros #droscrew
recently

RECAP 8/6 +Pos Comments: $BFIN + Janney RECAP 8/6 -Neg Comments: $DUK - Vertical $PANW - OTR $XENT - Canaccord $BCRX - Jefferies $SRLP - Seeking Alpha $GLPG - DB $CGNX - HSBC

60 Replies 14 👍 6 🔥

profile
@Pyrognosis #droscrew
recently

we may have missed XENT but there are more companies losing more money to invest in

107 Replies 8 👍 6 🔥

profile
@Pyrognosis #droscrew
recently

we seem to have missed $XENT move

83 Replies 8 👍 11 🔥

Key Metrics

Market Cap

0

Beta

0

Avg. Volume

0

Shares Outstanding

33.81 M

Yield

0%

Public Float

0

Next Earnings Date

Next Dividend Date

Company Information

Intersect ENT is a global ear, nose and throat medical technology leader dedicated to transforming patient care. The Company's steroid releasing implants are designed to provide mechanical spacing and deliver targeted therapy to the site of disease. In addition, Intersect ENT is continuing to expand its portfolio of products based on the Company's unique localized steroid releasing technology and is committed to broadening patient access to less invasive and more cost-effective care. In October 2020, Intersect ENT acquired Fiagon AG Medical Technologies, a global leader in electromagnetic surgical navigation solutions with an expansive portfolio of ENT product offerings, including the VENSURE sinus balloon, that complement the Company's PROPEL® and SINUVA® sinus implants and extend its geographic reach.

CEO: Thomas West

Website:

HQ: 1555 Adams Dr Menlo Park, 94025-1439 California

Related News